PANACEABIO
UnclassifiedPanacea Biotec Limited
₹352.70
+1.10(0.31%)
EMA 9: 350.73EMA 21: 347.44RSI: 50.8MACD: 0.26ATR: 15.74
Overlays
RSI (14)
Open
₹352.60
High
₹361.00
Low
₹344.40
Close
₹352.70
Volume
76,311
Panacea Biotec Limited (PANACEABIO) last closed at ₹352.7 on 17 Nov 2026, 45.5% below its 52-week high. Price is below both the 50-day and 200-day averages. Volume in the last session was close to the 20-day average. The scanner currently flags Volume Breakout.
1 week
-2.2%
1 month
-1.9%
3 months
-14.6%
52-week high
₹647
-45.5% from high
52-week low
₹292.4
Volume vs 20-day
0.99×
Active signals
Volume BreakoutBULLISH
New today+0.3%
Signal history
| Dates | Signal | Type | Lasted | Quality | Move |
|---|---|---|---|---|---|
| 13 Nov | MACD Bullish Crossover | BULLISH | 1d | Q47 | — |
| 09 Nov | Volume Breakout | BULLISH | 1d | Q58 | — |
| 09 Nov | 20-Day High Breakout | BULLISH | 1d | Q58 | — |
| 09 Nov | EMA Crossover (9/21) | BULLISH | 1d | Q58 | — |
| 19 Oct – 30 Oct | Downtrend Alignment | BEARISH | 8d | Q26 | -10.3% |
| 15 Oct | Downtrend Alignment | BEARISH | 1d | Q24 | — |
| 24 Sept – 12 Oct | Downtrend Alignment | BEARISH | 12d | Q19 | -7.4% |
| 15 Sept – 21 Sept | Downtrend Alignment | BEARISH | 5d | Q31 | +0.1% |
| 10 Sept | Downtrend Alignment | BEARISH | 1d | Q22 | — |
| 24 Aug – 07 Sept | Downtrend Alignment | BEARISH | 10d | Q11 | -6.8% |
| 18 Aug – 19 Aug | Downtrend Alignment | BEARISH | 2d | Q17 | -0.8% |
| 23 Jul | MACD Bearish Crossover | BEARISH | 1d | Q28 | — |
| 22 Jul – 14 Aug | Downtrend Alignment | BEARISH | 17d | Q37 | -14.2% |
| 22 Jul | EMA Death Cross (9/21) | BEARISH | 1d | Q37 | — |
| 21 Jul | Volume Breakout | BULLISH | 1d | Q49 | — |
| 16 Jul – 20 Jul | Strong Uptrend Alignment | BULLISH | 3d | Q60 | -2.7% |
| 09 Jul – 10 Jul | Strong Uptrend Alignment | BULLISH | 2d | Q54 | -1.6% |
| 02 Jul – 03 Jul | Strong Uptrend Alignment | BULLISH | 2d | Q43 | +0.5% |
| 23 Jun – 30 Jun | Strong Uptrend Alignment | BULLISH | 5d | Q52 | +2.3% |
Technical data for educational purposes only — not investment advice